Stay updated with breaking news from Enabling Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare Fortrea to similar companies based on the strength of its valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Valuation and Earnings This table compares Fortrea […]
DURHAM, N.C., May 06, 2024 -- Fortrea , a leading global contract research organization , today announced an updated issuance date for the company’s first quarter 2024 financial results. The...
Vyant Bio (OTCMKTS:VYNT – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends. Profitability This table compares Vyant Bio and Fortrea’s net […]
Fortrea (FTRE) posted a fourth quarter GAAP net loss of $36.0 million and loss per share of $0.41 compared to net income of $33.4 million and earnings per share of $0.
For the three months and full year ended December 31, 2023: Revenues of $775.4 million for the fourth quarter, $3,109.0 million for the full yearGAAP net loss of $ million for the fourth quarter, $...